Scanning BioElectronics Corporation (BIEL.PK)

“This is a very important and significant event for BioElectronics. As consumers and the U.S. Food and Drug Administration become increasingly aware of the potential dangers of drugs such as acetaminophen, consumers are increasingly searching for alternatives,” commented Andrew Whelan, CEO of BioElectronics. “PEMF therapy is a proven safe and effective alternative for many musculoskeletal disorders and there is a growing body of research showing its effectiveness in speeding surgical recovery and in reducing, or completely eliminating, the amount of pain medication required. This patent ensures our ability to be the sole provider of this technology in a wearable and portable form factor and significantly increases the value of our Company.”

Market Club has a very interesting take on how BIEL is playing out after the past volume surge. The “Trade Triangles” paint the picture. CLICK HERE and just enter the ticker (BIEL) your name and e-mail address for the FREE No strings Attached Report sent realtime to your in-box!

FREE Trend Analysis for BIEL Here

Comment on this post below.